Medication Assisted Treatment (MAT)
ARI offers Methadone and buprenorphine maintenance treatment as part of a medication assisted treatment (MAT) model for opioid dependence. This involves the use of medications in combination with counseling and behavioral therapies to provide a whole-patient approach to the treatment of substance use disorders.
ARI believes that each patient should be treated in the least restricted level of care. To accomplish this, ARI will follow the outlined phase system listed below.
For mandated patients periods of abstinence to complete the program must be consistent, with any relapse resulting in a new agreed upon time period. In order to complete successfully there must be a successful time period of abstinence so that the counselor can determine whether or not co –occurring disorders are being “masked” by self-medication. After completion of this time period, the counselor can then be confident that 1) the patient has been able to cease use of the substance in question and 2) that no co –occurring disorder is being “masked”.
Mandated patients can continue counseling even after their mandated portion is complete to ensure success. In fact, this is highly recommended in patients that respond well to Outpatient treatment.
To begin treatment, patient must abstain from using opioids for at least 12 to 24 hours and be in the early stages of opioid withdrawal. Patents with opioids in their bloodstream or who are not in the early stages of withdrawal, may experience acute withdrawal.